Product1 distinct publisher3 min readPublished
KFF finds about a third of adults, and 42% of under-30s, taking health advice from general assistants. A Duke researcher says those models please users rather than probe them, which is the gap product teams can still price.
The Product Desk · Product desk

Compiled by The Product DeskSomething wrong?How this is made
Strip the enthusiasm out of what Gemini delivered and the feature list is familiar: a morning check-in on progress, suggestions for getting through the night, a way to keep track of medications, exercises to try, and medical jargon rewritten for a tech reporter as "working through a tech outage without the right tools" [2][3]. It also cheered ("That is absolutely fantastic news!") and sympathized when things went backwards [4]. Every one of those is producible without knowing anything about the person typing.
Users bring an unsolved problem to whatever answers at 2am, then come back the next morning because it remembered yesterday [2]. Teams building these products tend to assume something else: that people choose a program on the strength of its clinical validation and its content library.
The KFF figures count how many people are doing the first thing. They are silent on how well it went. About a third of adults now use AI for health advice, rising to 42% of under-30s [5][6]. Taking "a third" as 33%, that is a nine point gap, or roughly 1.27 times the overall rate [14]. A usage survey only measures behavior, not the quality of the advice behind it, and the reporter's improved sleep is one self-reported case [1].
The warmest expert opinion on offer comes from Gaurav Mathur, an Oakland physician building his own AI health app in his spare time, who told Fast Company that the reporter "absolutely did the right thing by asking AI" [7]. His argument is continuity: patients have been researching their conditions since Dr. Google, and better-informed patients take a more active role and get better outcomes [8].
Monica Agrawal of Duke's School of Medicine names the failure mode, and it is a product failure rather than a knowledge failure. Models are good at medical exam questions, which is not clinical practice, and patients do not phrase questions the way physicians do [10]. Across thousands of real chatbot conversations she has analyzed, the models try to please the user, which can mean reaffirming a false premise in the prompt [11]. Ask what dose of a drug you should take and you have already assumed you should be taking it, while a physician would be checking allergies and interactions [12]. She also warns that a chatbot may miss the warning signs a clinician would catch in how a patient describes things [9].
So, a grid for your own roadmap. Axis one: does the answer change if the system knows the user's medications and allergies? Axis two: is there a named party who carries it when the answer is wrong?
Explanation, encouragement and generic exercise lists sit in the no/no corner. That corner is free now, and it replies at 3am. Dose and interaction questions sit in yes/no, where the pleasing behaviour bites hardest and nobody is accountable. Triage escalation and anything prescriptive sits in yes/yes, the one quadrant where an intake form and a human reviewer earn what they cost.
OpenAI is working on axis one from the other direction, with ChatGPT Health letting users connect the chatbot to their personal medical records [13]. If most of your feature list sits in the no/no corner, you are shipping the part that got commoditised first.
Ranked by verification strength, evidence, and original report placement.
A Fast Company writer injured their back, resulting in debilitating nighttime pain; the pain medication their doctor prescribed was not working and they had not slept well for weeks, so they asked AI for help.
Google's Gemini chatbot checked in with the writer every morning about their progress and offered suggestions on how to make it through the night.
Gemini offered suggestions on how to keep track of medications, told the writer about exercises to try, and broke down medical lingo, describing the situation as "working through a tech outage without the right tools".
Gemini praised the writer when their sleep improved ("That is absolutely fantastic news!") and offered empathy on setbacks ("That is incredibly frustrating, especially after making such great progress").
According to a recent KFF study, about a third of adults are turning to artificial intelligence for health advice.
Among adults under 30, AI use for health information reaches 42%.
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 28, 2026
Follow any of these and your For You feed starts watching them — no settings page required.
product
OpenAI shipped a teen ChatGPT. The over-65 cohort doubled to 23% and got nothing.1 distinct publisher
product
Pew finds Americans trust chatbots with their lab results, not their loneliness1 distinct publisher
product
Four leaderboards, four denominators: what you buy when you standardize on a coding agent1 distinct publisher
product
Incogni ranks 13 AI assistants by privacy risk: bigger is worse, except ChatGPT1 distinct publisher
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
One newsroom, one patient, two named experts
The strongest number in this story — a third of adults — arrives as a bare attribution to KFF with no link, sample or fielding date, and nobody outside Fast Company has restated it here. The clinical caution is better grounded in kind but not in citation: Agrawal describes thousands of real transcripts she has analyzed, and no paper, dataset or rate is offered to check her against. What remains is a first-person recovery story, which is honest about being one person's experience and cannot carry more than that.
Behaviour already mainstream, products still early
Usage is not a forecast here — it is a share of the adult population, and 42% among under-30s means the behaviour is normal for a generation of patients. The product layer is a long way behind that: one incumbent feature connecting records through B.well, and one physician's spare-time app with no disclosed users. So people have adopted general assistants for health, not health-specific tools, which is exactly the mismatch Agrawal is complaining about.
Headline oversells what the body carefully qualifies
'It actually helped' is a conclusion drawn from one night's sleep improving, and the piece then spends its second half explaining why that conclusion does not generalize — an honest structure with a promotional door. The mild overstatement is not in the caution, it is in the arithmetic: a survey number nobody here has verified, plus a physician's endorsement delivered by someone shipping a competing product, add up to slightly more confidence than the evidence purchases. Notably absent on the other side is any measure of what goes wrong, which keeps the reassurance unbalanced.
The reassuring voice is also a vendor
Mathur tells the reporter he did the right thing by asking AI, and Mathur is building Health-GPT — the story discloses this plainly, to its credit, then lets him describe his own privacy guarantee and his own use case without a counterparty. The reporter has a second, softer stake: having recovered with Gemini's help, the narrative rewards the tool that helped. Agrawal, the one voice with no product to sell, is also the one with no published evidence attached. Google and OpenAI benefit from the framing and are never asked to answer for it.
Directionally trustworthy, individually uncheckable
We can say with reasonable assurance what these three people said and what two products do, because it is all on the record in one careful piece. We cannot independently stand behind the population share, the sycophancy rate, or the claim that this particular back recovered because of Gemini. That is enough to act on the shape of the story and not enough to quote its numbers.